The provision of optimal analgesia after caesarean section remains a challenge as satisfactory pain relief must be combined with patient satisfaction, including the ability to care for the newborn. In a prospective study of 132 patients, we have compared epidural analgesia with intravenous patient-controlled analgesia (IVPCA) after either epidural or general anaesthesia. Different bolus doses of opioid (pethidine 10 mg and 20 mg) in the IVPCA group were also compared. Although epidural morphine provided the greatest efficacy (average pain score out of 10 was 1.8 v. 2.9-3.4 for the other groups), IVPCA, especially with a bolus dose of 20 mg, and especially after epidural anaesthesia, provided the greatest patient satisfaction with the least side-effects.
comparing epidural morphine and patient-controlled intravenous analgesia focused only on pain scores. 4 • 5 More recent studies have compared side-effects, patient satisfaction and pain scores between epidural, intramuscular and IVPCA analgesia, but have not examined the effect of different bolus doses of IVPCA opioid. 6 Furthermore, in previous studies, a substantially larger dose of epidural morphine was used (5 mg) compared with that used in our study (3.5 mg) . [3] [4] [5] The present investigation was designed to extend a former study of epidural and continuous intravenous opioid analgesia after caesarean section' by comparing epidural opioid analgesia with the newer intravenous technique of PCA using two different bolus doses. Moreover, since pethidine proved superior to morphine in terms of side-effects (especially nausea and vomiting) when given intravenously to obstetric patients,' pethidine was chosen as the intravenous agent in the present study. As in previous studies, morphine was used epidurally since it may be administered as a single dose with at most one top-up after caesarean section.
PATIENTS AND METHODS

Procedure
All patients undergoing elective caesarean section between the hours of 8 am and 2 pm were eligible for inclusion. The only criteria for exclusion were unwillingness of an individual patient or her anaesthetist to participate, or previous sensitivity of the patient to morphine or pethidine.
The decision for general or epidural anaesthesia was based on patient preference after anaesthetic consultation. An explanation was given preoperatively of the pain scale to be used postoperatively by the patient. This scale was a simple visual analogue one, with an estimation requested from 1 to 10.
General anaesthesia was performed using a standard rapid-sequence induction technique with thiopentone and suxamethonium, and maintenance with nitrous oxide/oxygen (50:50 pre-delivery, then 70:30), enflurane (up to 1.5070) and atracurium (0.3 mg/kg).
Epidural anaesthesia was performed using lignocaine 2070 with 1:200,000 adrenaline given through an 18-gauge epidural catheter at the L2-L3 or L3-L4 interspace.
Postoperatively, the epidural anaesthesia group was randomly divided according to a computer-generated sequence of random numbers into three sub-groups to receive either an initial epidural injection of morphine sulphate (3.5 mg in 5 ml saline) or IVPCA with bolus doses of either 10 mg or 20 mg of pethidine, each with a lockout interval of 5 min following a loading dose of 1.5 mg/kg IV over 5 min. The general anaesthesia group received PCA, similarly randomly divided into two sub-groups to receive either bolus dose of pethidine.
The postoperative regimen was commenced on completion of the operation or at the time when pain was first reported (whichever was sooner). Naloxone was kept at the bedside for emergency treatment of respiratory depression (in incremental doses of 0.1 mg to a maximum of 0.4 mg) and as the recommended treatment for severe pruritus (in incremental doses of 0.04 mg to a maximum of 0.12 mg). All patients were nursed in the post-natal wards in specific areas of increased nursing surveillance allocated routinely to patients immediately following caesarean section.
Assessment
At approximately 24 hours (range 22-26 hr), the following assessments were made by the anaesthetic research nurse or by a medical member of the anaesthetic staff. 1. Details of analgesia, viz. duration of analgesia and number of top-ups for the epidural group and dose rate and total dose for the IVPCA groups. 2. Side-effects noted and severity recorded (semiquantitatively graded 1, 2 or 3), with particular reference to nausea, vomiting, drowsiness, dizziness, pruritus and paraesthesia. Respiratory depression was defined as a respiratory rate of less than 10 breaths per minute and was assessed from the nursing observations of respiratory rate (measured every 15 min for 2 hours then every hour for 24 hours). 3. Patient awareness of the overall pain felt during the preceding 24 hours, as assessed by a score from 1 to 10 at this time using the previously explained pain scale. 4. Overall quality of pain relief, as assessed by the patient and expressed semi quantitatively as excellent, good, fair or poor. Patients were also asked if they would like the same form of analgesia again on a future occasion.
Analyses
Between-group analyses were made by contingency analysis for discrete variables and by analysis of variance for continuous variables, using conventional levels of statistical significance.
Ethics
The study was approved by the Hospital's Ethics Committee and written informed consent was given by all participating patients. As in a previous study/ a double-blind trial design was not considered ethical or practical.
RESULTS
Of the 132 patients entered in the study, only 27 (20%) elected to have general anaesthesia for delivery by caesarean section. This is in accord with the overall general anaesthesia rate for elective caesarean section in this institution. Most patients (84%) were muItigravid.
There were no statistically significant differences between the five treatment groups with respect to age, weight, ASA status, smoking history, patient compliance or gravid status.
For intravenous PCA pethidine, the average dose over 24 hours with 10 mg bolus doses was 496 mg (range 110-1000 mg) and with 20 mg doses was 525 mg (range 200-1136 mg). For epidural morphine, 87% of patients received only the initial dose (3.5 mg) and the remaining 13% received one top-up (also 3.5 mg) at an average of 18 hours (range 7-22 hr).
The incidence of postoperative side-effects among the five treatment groups is shown in Figure 1 . With epidural morphine, nausea, vomiting, dizziness and pruritus were significantly more frequent (P=0.003, 0.006, 0.05 and 0.0001, respectively) and drowsiness was significantly less frequent (P=0.05) compared with any other group. Numbness was uncommon and was not significantly different between groups (P=0.22). There were no instances of respiratory depression.
Pain scores for the five treatment groups are shown in Figure 2 . The scores after epidural morphine (mean 1.8) were significantly less than for all other groups (mean 2.9-3.4), which in turn were comparable among themselves (P=0.005).
The quality of pain relief in the five treatment groups is shown in Figure 3 . It was significantly better after epidural anaesthesia with either epidural morphine or IVPCA with 20 mg bolus doses postoperatively (pain relief good or excellent in 100010 of cases) (P=0.03). Patient preference for the same form of analgesia on a future occasion was 84-100010 and was not significantly different between the treatment groups (P=0.36).
DISCUSSION
The provision of optimal analgesia after caesarean section remains a challenge, in that the chosen modality of pain relief must be effective but must not interfere with the mother's need to interact with her newborn infant. The establishment of a successful analgesia regimen in these difficult circumstances can also provide an interesting and potentially useful model of pain relief in other postoperative situations.
In a previous study' we demonstrated that epidural morphine offered superior analgesia compared with traditional nurse-administered intravenous opioid but had an increased incidence of side-effects, especially pruritus. In the present study we have compared epidural morphine with newer patient-controlled intravenous opioid analgesia. As shown previously with epidural morphine, the levels of analgesia recorded as pain scores were least and side-effects, again particularly pruritus, were more frequent. As in our former study,2 we did not formally assess patient mobility, but the nursing staff again indicated that patients given epidural morphine were more alert and more easily able to mobilise and care for their babies than patients receiving intravenous PCA opioid. However, there was a marked patient preference for patient-controlled intravenous analgesia, as has also been reported in other studies. 3 -6 This has been attributed to the increased control of the patient over her own pain relief, with immediate accessibility of analgesia and an ability to titrate analgesia against side-effects.
Within the IVPCA group there was no significant difference in total dose between the two bolus doses prescribed. Clearly, patients receiving the smaller bolus dose of 10 mg must demand twice as often, a fact which theoretically could be more disturbing, particularly at night. However, the patients using IVPCA of either bolus dose did not complain of being awakened at night in pain and were not disturbed greatly by the need to self-medicate overnight. On the other hand, IVPCA with 20 mg doses was as effective as epidural morphine in providing the highest quality of pain relief, reported as good or excellent in 100010 of cases. This high level of analgesic quality from IVPCA with 20 mg bolus doses was achieved with no more side-effects than with 10 mg doses.
Epidural morphine is widely used for analgesia after caesarean section. Recent reports confirm that epidural morphine gives effective and prolonged analgesia for a mean of 23 hours in doses from 2-5 mg. 7 The safety of epidural morphine is also well documented. For example, in a study of almost 5000 Canadian women, while pruritus, nausea, vomiting and dizziness were common (with respective incidences of 60010, 40010, 40010 and 10010), the incidence of bradypnoea was only 0.25010 and there were no serious sequelae of respiratory depression. 8 Although a lower dose of epidural morphine (3.5 mg) is now more commonly used with equal analgesic effect, pruritus remains a common and often troublesome complication. In addition, reports of recurrent oral herpes simplex lesions in susceptible parturients following epidural morphine are disturbing;,IO although none has been observed in our own studies.
More recently, patient-controlled intravenous analgesia appears to offer an excellent alternative to epidural morphine, with enhanced patient satisfaction and decreased side-effects compared with epidural, intramuscular 6 and continuous intravenous opioid analgesia.' Compared with bolus doses of 10 mg, doses of 20 mg of pethidine provided improved quality of analgesia but without increased side-effects, perhaps because the total daily dose was the same with either regimen. Further refinements in PCA dosage may perhaps be seen in the future with the advent of new "smart" pumps which are programmed to adjust doses to individual patient requirements.
In conclusion, epidural opioid remains a highly effective, simple and well received form of analgesia after caesarean section in suitable patients, particularly those with no history of oral herpes simplex. If PCA pumps are available, this form of intravenous opioid analgesia provides an excellent alternative.
